Recently, the National Medical Products Administration (NMPA) issued the draft version of 'Implementation Measures for Drug Trial Data ...
Q4 2024 Earnings Call Transcript March 31, 2025 Omeros Corporation beats earnings expectations. Reported EPS is $-0.54, ...
Security forces have suffered heavy losses, with 56 personnel killed between March 2 and March 20, per the Pakistan Institute for Conflict and Security Studies. Meanwhile, Baloch separatists have ...
For decades, Pakistan’s military has manipulated democracy while maintaining a facade of stability. That illusion is now ...
Despite a significant net loss, Omeros Corp (OMER) focuses on strategic partnerships and a promising pipeline to bolster its ...
LANGHORNE, PA — Savara Inc. (Nasdaq: SVRA) has announced its financial results for the fourth quarter and fiscal year 2024, ...
Otsuka Pharmaceutical Development & Commercialization, Inc. and Otsuka Pharmaceutical Co., Ltd. (Otsuka) today announce the ...
Alvotech's 427% revenue surge in 2024—fueled by its biosimilar portfolio and global expansion—highlights the booming ...
Otsuka Pharmaceutical Development & Commercialization Inc. filed its BLA with the U.S. FDA for sibeprenlimab to treat immunoglobulin A nephropathy (IgAN). The company’s first BLA, sibeprenlimab is a ...
DC orders bar mostly public transport on arteries connecting Karachi, Sukkur, DI Khan, Multan, to Quetta, Gwadar, and other cities.
Despite being Pakistan’s largest province and endowed with natural gas reserves and strategic access to the Arabian Sea, ...
Cretostimogene Monotherapy Demonstrated Sustained, Durable Complete Responses in High-Risk Bacillus Calmette Guérin (BCG)-Unresponsive ...